Skip to content

AOCI at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$651M+17.1%
Biogen logo
BiogenBIIB
-$140.2M+19.7%
Alkermes logo
AlkermesALKS
-$2.91M-99.9%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$400K-95.6%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
-$1.62M-516%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM

Other financials

Income statement

See full
Revenue--100%
Operating income-$105.9M-41.7%
Net income-$92.6M-33.6%
EPS (diluted)-$3.20+2.7%

Balance sheet

See full
Cash & equivalents$536.7M+223%
Total debt$1.4M+31.3%
Total equity$1.4B+221%
Total assets$1.5B+205%

Cash flow

See full
Operating cash flow-$86.2M-62.5%
CapEx$62.0K
Free cash flow-$86.2M-62.6%

Valuation

See full
Market cap$7.87B+1,075%
Enterprise value$7.34B+1,309%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-35.3%-10.9pp
Debt / equity0.0×
Current ratio15.9×+7.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s AOCI?
Praxis Precision Medicines, Inc. (PRAX) reported AOCI of -$1.59M in Q1 2026.
How has Praxis Precision Medicines, Inc.'s AOCI changed year-over-year?
Praxis Precision Medicines, Inc.'s AOCI decreased by 341.9% year-over-year, from $659K to -$1.59M.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.